Pranesh Chakraborty, MD, FRCPC, FCCMG

Innovative Therapies Pillar Member

Dr. Pranesh Chakraborty is an Associate professor at the University of Ottawa and physician certified by the Royal College in Medical Biochemistry and Pediatrics, with a subspecialty in Biochemical Genetics. He led the transition of Ontario’s newborn screening program to Ottawa leading to the establishment of Newborn Screening Ontario (NSO) at CHEO. He was instrumental in the founding of the Better Outcomes Registry and Network (BORN Ontario) at CHEO as a prescribed registry in Ontario and was the Medical Director of BORN until 2017. In addition to leading the research program within NSO, Dr. Chakraborty is a Principal Investigator for the Canadian Inherited Metabolic Disease Research Network (CIMDRN).

Skip to content